SCPH -

QQQ ()

DIA ()

SPY ()

TLT ()

GLD ()

Previous Close

$ na

Open

Bid

-- x --

Ask

-- x --

Day's Range

-- - --

52 Week Range

-- - --

Volume

Average Volume

Market Cap

Beta (5Y Monthly)

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

-- (--)

Last Ex-Dividend

1y Target Est

TBD --

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type	Report Link
No Data found

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Craig-Hallum Downgrades scPharmaceuticals ...
08/26/2025 18:01:14

Craig-Hallum analyst Chase Knickerbocker downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold and announces $6 price ...

Maxim Group Downgrades scPharmaceuticals t...
08/25/2025 18:57:36

Maxim Group analyst Naz Rahman downgrades scPharmaceuticals (NASDAQ:SCPH) from Buy to Hold.

mannkind-backed-by-blackstone-expands-cardiorenal-focus-with-360-million-deal

MannKind, Backed By Blackstone, Expands Ca...
08/25/2025 17:57:32

MannKind will acquire scPharmaceuticals in a $360 million deal, adding Furoscix and expanding into cardiometabolic care with a ...

12 Health Care Stocks Moving In Monday's P...
08/25/2025 12:08:04

Trading Halt: Halt status updated at 7:55:...
08/25/2025 11:55:14

MannKind To Acquire scPharmaceuticals For ...
08/25/2025 11:33:57

Trading Halt: Halted at 7:25:00 a.m. ET - ...
08/25/2025 11:25:06

scPharmaceuticals Secures 5 New USPTO Pate...
08/14/2025 12:41:28

scPharmaceuticals Inc. (NASDAQ:SCPH) (the "Company"), a pharmaceutical company committed to revolutionizing cardiorenal...

scPharmaceuticals Q2 EPS $(0.34) Misses $(...
08/07/2025 20:04:28

scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

scPharmaceuticals Q1 EPS $(0.37) Misses $(...
05/14/2025 20:04:54

scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $...

Earnings Scheduled For May 14, 2025
05/14/2025 08:32:23

Insights Ahead: scPharmaceuticals's Quarte...
05/13/2025 19:04:01

Analyst Expectations For scPharmaceuticals...
03/20/2025 20:00:33

Maxim Group Maintains Buy on scPharmaceuti...
03/20/2025 14:59:46

Maxim Group analyst Naz Rahman maintains scPharmaceuticals (NASDAQ:SCPH) with a Buy and lowers the price target from $20 to ...

HC Wainwright & Co. Reiterates Buy on scPh...
03/20/2025 10:15:00

HC Wainwright & Co. analyst Douglas Tsao reiterates scPharmaceuticals (NASDAQ:SCPH) with a Buy and maintains $18 price t...

scPharmaceuticals Q4 2024 GAAP EPS $(0.35)...
03/19/2025 20:03:20

scPharmaceuticals (NASDAQ:SCPH) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0...

Earnings Scheduled For March 19, 2025
03/19/2025 08:32:11

HC Wainwright & Co. Reiterates Buy on scPh...
03/07/2025 12:15:00

HC Wainwright & Co. analyst Douglas Tsao reiterates scPharmaceuticals (NASDAQ:SCPH) with a Buy and maintains $18 price t...

scPharmaceuticals Announces FDA Approval F...
03/06/2025 21:03:01

SCPH

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Search Symbol

Create a Free Account Sign in to your Account Reset Password

SCPH

Create a Free Account Sign in to your Account Reset Password

News

OPINIONS

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

Add/Delete Symbol to your Portfolio